Clinical Trial Treatment Report

Category: Others

See also: ALS Phase 1 Study NP001, ALS Phase 2B Study CK-2017357, ALS Phase 2 Study Lithium Carbonate, ALS Phase 2 Study NP001, ALS Phase 3 Study Ceftriaxone, ALS Phase 3 Study Dexpramipexole (KNS-760704), ALS Phase 3 Study TRO19622, Epilepsy Phase 3 Study Retigabine IR, FTY720 (Fingolimod) Clinical Trial, Gc Protein-derived Macrophage Activating Factor (GcMAF), Kidney Transplant Phase 3 Belatacept BENEFIT, Mesothelioma Lung Cancer Phase 3 Study Vorinostat, MS HOPE Study Apoaequorin, MS Phase 2 Study ACT-128800, MS Phase 2 Study Nerispirdine (HP184), MS Phase 2 Study ONO-4641, MS Phase 3 Fingolimod FREEDOMS, MS Phase 3 Fingolimod TRANSFORMS, MS Phase 3 Study CombiRx, MS Phase 3 Study DECIDE, MS Phase 3 Study Fingolimod, MS Phase 3 Study Fingolimod FREEDOMS II, MS Phase 3 Study Laquinimod, MS Phase 3 Study Laquinimod BRAVO, MS Phase 3 Study Teriflunomide (HMR1726) TOWER, Multiple Myeloma Phase 2 Study Carfilzomib, Parkinson's Phase 3 Study CoQ10 QE3, Parkinson's Phase 3 Study Creatine, Parkinson's Phase 3 Study IPX066 APEX-PD, Parkinson's Phase 3 Study Safinimide, Plaque Psoriasis Phase 3 Study CP-690,550, RA Phase 2-3 Study Tasocitinib (CP-690,550)